Cargando…
Apolipoprotein E and Alzheimer's disease
Genetic variation in apolipoprotein E (APOE) influences Alzheimer's disease (AD) risk. APOE ε4 alleles are the strongest genetic risk factor for late onset sporadic AD. The AD risk is dose dependent, as those carrying one APOE ε4 allele have a 2–3-fold increased risk, while those carrying two ε...
Autores principales: | Troutwine, Benjamin R., Hamid, Laylan, Lysaker, Colton R., Strope, Taylor A., Wilkins, Heather M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897057/ https://www.ncbi.nlm.nih.gov/pubmed/35256931 http://dx.doi.org/10.1016/j.apsb.2021.10.002 |
Ejemplares similares
-
Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer’s disease
por: Flannagan, Kaitlin, et al.
Publicado: (2023) -
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
por: Williams, Tosha, et al.
Publicado: (2020) -
Function and Comorbidities of Apolipoprotein E in Alzheimer's Disease
por: Leduc, Valérie, et al.
Publicado: (2011) -
Targeting Apolipoprotein E for Alzheimer’s Disease: An Industry Perspective
por: Suidan, Georgette L., et al.
Publicado: (2019) -
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
por: Najm, Ramsey, et al.
Publicado: (2019)